{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:16:42Z","timestamp":1789064202185,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.retram.2022.103363","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T18:07:38Z","timestamp":1661710058000},"page":"103363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiovascular diseases in patients after hematopoietic stem cell transplantation: Systematic review and Meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Azin","family":"Alizadehasl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashmil","family":"Ghadimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Hosseinifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Roudini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardeshir","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"khoda-Amorzideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.retram.2022.103363_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ejh.13482","article-title":"Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant","volume":"106","author":"Alblooshi","year":"2021","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.retram.2022.103363_bib0002","first-page":"35967","article-title":"Impact of guideline-driven approach in follow-up of long-term complications after allogeneic hematopoietic cell transplant: single center experience","volume":"18","author":"Kaya","year":"2018","journal-title":"Exp Clin Transplant"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0003","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3324\/haematol.2011.048348","article-title":"Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how","volume":"96","author":"Ribera","year":"2011","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.retram.2022.103363_bib0004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7861\/clinmedicine.18-4-329","article-title":"Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases\u2013a guide for the generalist","volume":"18","author":"Snowden","year":"2018","journal-title":"Clin Med"},{"issue":"3","key":"10.1016\/j.retram.2022.103363_bib0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaccao.2020.06.011","article-title":"Left ventricular systolic function in long-term survivors of allogeneic hematopoietic stem cell transplantation","volume":"2","author":"Massey","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.retram.2022.103363_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4070\/kcj.2015.45.1.51","article-title":"Early left ventricular dysfunction in children after hematopoietic stem cell transplantation for acute leukemia: a case control study using speckle tracking echocardiography","volume":"45","author":"Yoon","year":"2015","journal-title":"Korean Circ J"},{"key":"10.1016\/j.retram.2022.103363_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.retram.2022.103363_bib0008","series-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","first-page":"1","author":"Peterson","year":"2011"},{"issue":"34","key":"10.1016\/j.retram.2022.103363_bib0009","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1200\/JCO.2008.17.7428","article-title":"Late congestive heart failure after hematopoietic cell transplantation","volume":"26","author":"Armenian","year":"2008","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.retram.2022.103363_bib0010","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","article-title":"Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.retram.2022.103363_bib0011","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.retram.2022.103363_bib0012","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/bloodadvances.2018019117","article-title":"Prediction of cardiovascular disease among hematopoietic cell transplantation survivors","volume":"2","author":"Armenian","year":"2018","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0013","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41409-018-0104-x","article-title":"Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age","volume":"53","author":"Borchert-M\u00f6rlins","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.retram.2022.103363_bib0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbmt.2007.10.027","article-title":"Cardiac chamber hypertrophy following hematopoietic stem cell transplantation for primary immunodeficiency","volume":"14","author":"Bulley","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.retram.2022.103363_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41409-020-0978-2","article-title":"Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"9872","key":"10.1016\/j.retram.2022.103363_bib0016","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","article-title":"Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis","volume":"381","author":"Burt","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.retram.2022.103363_bib0017","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/hrt.2007.123299","article-title":"Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function","volume":"94","author":"Chung","year":"2008","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.retram.2022.103363_bib0018","doi-asserted-by":"crossref","first-page":"e26513","DOI":"10.1002\/pbc.26513","article-title":"Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients","volume":"64","author":"Dandoy","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.retram.2022.103363_bib0019","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MPH.0000000000000974","article-title":"Incidence and outcome of pericardial effusion in pediatric patients after hematopoietic stem cell transplant: a single-institution experience","volume":"40","author":"Diamond","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.retram.2022.103363_bib0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/PCC.0b013e3182720601","article-title":"Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant","volume":"14","author":"Duncan","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0021","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/leu.2009.1","article-title":"The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation","volume":"23","author":"Farina","year":"2009","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0022","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ajh.21459","article-title":"Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation","volume":"84","author":"Fatema","year":"2009","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0023","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10067-017-3954-5","article-title":"Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis","volume":"37","author":"Helbig","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.retram.2022.103363_bib0024","doi-asserted-by":"crossref","DOI":"10.1186\/s42358-021-00166-8","article-title":"Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience","volume":"61","author":"Henrique-Neto","year":"2021","journal-title":"Adv Rheumatol"},{"issue":"7","key":"10.1016\/j.retram.2022.103363_bib0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.bmt.1704623","article-title":"Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"34","author":"Hidalgo","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.retram.2022.103363_bib0026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1702466","article-title":"Cardiac systolic function before and after hematopoietic stem cell transplantation","volume":"26","author":"Lehmann","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.retram.2022.103363_bib0027","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.retram.2022.103363_bib0028","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2009.05.010","article-title":"Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0029","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00277-020-03990-y","article-title":"Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes","volume":"99","author":"Masaharu","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.retram.2022.103363_bib0030","series-title":"Therapeutic advances in cardiovascular disease","author":"Meka","year":"2008"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0031","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ijcard.2012.06.021","article-title":"Heart failure after allogeneic hematopoietic stem cell transplantation","volume":"167","author":"Mo","year":"2013","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0032","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1399-3046.2010.01389.x","article-title":"Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Motoki","year":"2010","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.retram.2022.103363_bib0033","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977\u20131997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.retram.2022.103363_bib0034","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bmt.2010.149","article-title":"Pericardial effusion post-SCT in pediatric recipients with signs and\/or symptoms of cardiac disease","volume":"46","author":"Neier","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.retram.2022.103363_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bmt.2009.97","article-title":"Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation","volume":"45","author":"Peres","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0036","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/bmt.2017.62","article-title":"The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults","volume":"52","author":"Rotz","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.retram.2022.103363_bib0037","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.bmt.1704487","article-title":"Predictors for severe cardiac complications after hematopoietic stem cell transplantation","volume":"33","author":"Sakata-Yanagimoto","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0038","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2013.05.019","article-title":"Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation","volume":"19","author":"Singla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.retram.2022.103363_bib0039","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bmt.2012.253","article-title":"Factors affecting the development of atrial fibrillation and atrial flutter (AF\/AFL) following autologous hematopoietic SCT (auto-HSCT)","volume":"48","author":"Steuter","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0040","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bbmt.2010.12.698","article-title":"Retrospective outcome data for hematopoietic stem cell transplantation in patients with concurrent coronary artery disease","volume":"17","author":"Stillwell","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.retram.2022.103363_bib0041","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.bmt.1704610","article-title":"Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?","volume":"34","author":"Tang","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.retram.2022.103363_bib0042","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0043","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood Marrow Transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.retram.2022.103363_bib0044","doi-asserted-by":"crossref","first-page":"e13748","DOI":"10.1111\/petr.13748","article-title":"Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes","volume":"24","author":"Tinianow","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1016\/j.retram.2022.103363_bib0045","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bmt.2015.127","article-title":"Arrhythmias in the setting of hematopoietic cell transplants","volume":"50","author":"Tonorezos","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.retram.2022.103363_bib0046","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/annrheumdis-2020-217058","article-title":"Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study","volume":"79","author":"van Bijnen","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.retram.2022.103363_bib0047","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/s41409-018-0155-z","article-title":"Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation","volume":"53","author":"Duncan","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.retram.2022.103363_bib0048","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428194.2014.926346","article-title":"Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma","volume":"56","author":"Gul","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0049","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1753944712464102","article-title":"Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors","volume":"6","author":"Sureddi","year":"2012","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-021-00850-3","article-title":"Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)","volume":"22","author":"L\u00f3pez-Fern\u00e1ndez","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"10.1016\/j.retram.2022.103363_bib0051","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00612-2019","article-title":"Pulmonary hypertension after bone marrow transplantation in children","volume":"54","author":"Levy","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.retram.2022.103363_bib0052","first-page":"1","article-title":"Hypertension in oncology and stem-cell transplant patients","author":"Laskin","year":"2016","journal-title":"Pediatric Hypertension"},{"key":"10.1016\/j.retram.2022.103363_bib0053","series-title":"Prevalence and associated factors for arterial hypertension in adults following hematopoietic stem cell transplantation","author":"Chalela","year":"2019"},{"issue":"5","key":"10.1016\/j.retram.2022.103363_bib0054","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12185-019-02624-y","article-title":"Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome","volume":"109","author":"Lin","year":"2019","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.retram.2022.103363_bib0055","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/WNL.46.4.1004","article-title":"Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study","volume":"46","author":"Graus","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.retram.2022.103363_bib0056","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.hoc.2016.03.009","article-title":"Central nervous system complications of hematopoietic stem cell transplant","volume":"30","author":"Syed","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0057","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ejh.13322","article-title":"Arrhythmias in hematopoietic stem cell transplantation: A systematic review and meta-analysis","volume":"103","author":"Chiengthong","year":"2019","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1016\/j.retram.2022.103363_bib0058","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2022.103363_bib0059","series-title":"Mayo Clinic Proceedings","article-title":"Fatal coronary artery disease after unrelated donor bone marrow transplantation","year":"2004"},{"issue":"2","key":"10.1016\/j.retram.2022.103363_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.bmt.1702106","article-title":"Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation","volume":"25","author":"Ando","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.retram.2022.103363_bib0061","first-page":"213","article-title":"Pericardial effusion following conditioning for bone marrow transplantation in acute leukaemia","volume":"2","author":"Veys","year":"1987","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.retram.2022.103363_bib0062","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/petr.12062","article-title":"Pericardial effusion after pediatric hematopoietic cell transplant","volume":"17","author":"Aldoss","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.retram.2022.103363_bib0063","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbmt.2014.02.012","article-title":"Late cardiovascular complications after hematopoietic cell transplantation","volume":"20","author":"Chow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.retram.2022.103363_bib0064","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318622000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318622000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:41:42Z","timestamp":1762821702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318622000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2452318622000319"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2022.103363","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular diseases in patients after hematopoietic stem cell transplantation: Systematic review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2022.103363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103363"}}